AKT1 and cancer: MK-2206, another allosteric Akt inhibitor that has been studied in vitro and in vivo in many cancers, has shown interesting in vitro activity resulting in cell-cycle arrest, inhibition of cancer cell proliferation, and promotion of apoptosis in human HCC cell lines [72].